Author Liersch, Torsten

1 to 20 of 51 Items

2006 | Journal Article
Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC stage II/III after neoadjuvant chemoradiotherapy
Jakob, C.; Liersch, T.; Meyer, W.; Baretton, G. B.; Schwabe, W.; Haeusler, P. & Kulle, B. et al. (2006)
American Journal of Surgical Pathology, 30(9) pp. 1169-1174.
Details PMID PMC WoS

2006 | Conference Abstract
Pretherapeutical gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy and its impact on disease free survival
Grade, M.; Liersch, T.; Varma, S.; Difilippantonio, M. J.; Langer, C.; Simon, R. & Ried, T. et al. (2006)
EJC SUPPLEMENTS, 4(6) pp. 51-52.
Oxford: Pergamon-elsevier Science Ltd. DOI: https://doi.org/10.1016/j.ejcsup.2006.04.127
Details DOI WoS

2006 | Review
Molecular cytogenetics: Genomic imbalances in colorectal cancer and their clinical impact
Grade, M.; Becker, H.; Liersch, T.; Ried, T.& Ghadimi, B. M. (2006)
Cellular Oncology, 28(3) pp. 71-84.
Ios Press.
Details PMID PMC WoS

2006 | Journal Article
Distinct Chromosomal Profiles in Metastasizing and Non-Metastasizing Colorectal Carcinomas
Ghadimi, B. M.; Grade, M.; Mönkemeyer, C.; Kulle, B.; Gaedcke, J.; Gunawan, B. & Langer, C. et al. (2006)
Analytical Cellular Pathology, 28(5-6) pp. 273-281.
Details PMID PMC WoS

2006 | Journal Article
Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy
Liersch, T.; Langer, C.; Ghadimi, B. M.; Kulle, B.; Aust, D. E.; Baretton, G. B. & Schwabe, W. et al. (2006)
Journal of Clinical Oncology, 24(25) pp. 4062-4068. DOI: https://doi.org/10.1200/JCO.2005.04.2739
Details DOI PMID PMC WoS

2007 | Conference Abstract
Radioimmunotherapy post salvage resection of colorectal liver metastases
Goldenberg, D. M.; Meller, J.; Becker, H. & Liersch, T. (2007)
Cancer Investigation, 25
Philadelphia: Taylor & Francis Inc.
Details WoS

2007 | Conference Paper
Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: Results of study CAO/ARO/AIO-94
Fietkau, R.; Roedel, C.; Hohenberger, W.; Raab, R.; Hess, C.; Liersch, T. & Becker, H. et al. (2007)
International Journal of Radiation Oncology*Biology*Physics, 67(4) pp. 1008-1019. 25th Congress of the European-Society-for-Therapeutic-Radiology-and-Oncology, Leipzig, GERMANY.
New york: Elsevier Science Inc. DOI: https://doi.org/10.1016/j.ijrobp.2006.10.020
Details DOI PMID PMC WoS

2007 | Journal Article
Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas
Grade, M.; Hoermann, P.; Becker, S.; Hummon, A. B.; Wangsa, D.; Varma, S. & Simon, R. et al. (2007)
Cancer Research, 67(1) pp. 41-56. DOI: https://doi.org/10.1158/0008-5472.CAN-06-1514
Details DOI PMID PMC WoS

2007 | Journal Article
Nonprosthesis orthopedic applications of F-18 fluoro-2-deoxy-D-glucose PET in the detection of osteomyelitis
Meller, J.; Sahimann, C. O.; Liersch, T.; Tang, P. H. & Alavi, A. (2007)
Radiologic Clinics of North America, 45(4) pp. 719-+. DOI: https://doi.org/10.1016/j.rcl.2007.05.011
Details DOI PMID PMC WoS

2007 | Journal Article
Update of carcinoembryonic antigen radioimmunotherapy with (131)supercript stopI-Labetuzumab after salvage resection of colorectal liver metastases: Comparison of outcome to a contemporaneous control group
Liersch, T.; Meller, J.; Bittrich, M.; Kulle, B.; Becker, H. & Goldenberg, D. M. (2007)
Annals of Surgical Oncology, 14(9) pp. 2577-2590. DOI: https://doi.org/10.1245/s10434-006-9328-x
Details DOI PMID PMC WoS

2007 | Conference Paper
Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer
Roedel, C.; Liersch, T.; Hermann, R. M.; Arnold, D.; Reese, T.; Hipp, M. & Fuerst, A. et al. (2007)
Journal of Clinical Oncology, 25(1) pp. 110-117. Symposium on Gastrointestinal Cancer of the American-Society-of-Clinical-Oncology, San Francisco, CA.
Alexandria: Amer Soc Clinical Oncology. DOI: https://doi.org/10.1200/JCO.2006.08.3675
Details DOI PMID PMC WoS

2008 | Conference Abstract
Exploiting the genome and transcriptome for individualized cancer diagnosis and treatment stratification
Ried, T.; Grade, M.; Heselmeyer-Haddad, K.; Camps, J.; Hummon, A.; Emons, G. & Auer, G. et al. (2008)
Cellular Oncology, 30(2) Meeting of the International-Society-for-Cellular-Oncology (ISCO 2008), Amsterdam, NETHERLANDS.
Amsterdam: Ios Press.
Details WoS

2008 | Conference Paper
Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer
Roedel, C.; Arnold, D.; Hipp, M.; Liersch, T.; Dellas, K.; Iesalnieks, I. & Hermann, R. M. et al. (2008)
International Journal of Radiation Oncology*Biology*Physics, 70(4) pp. 1081-1086. 48th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology, Philadelphia, PA.
New york: Elsevier Science Inc. DOI: https://doi.org/10.1016/j.ijrobp.2007.07.2356
Details DOI PMID PMC WoS

2008 | Journal Article
Predictive value of Ki67 and p53 in locally advanced rectal cancer: Correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy
Jakob, C.; Liersch, T.; Meyer, W.; Becker, H.; Baretton, G. B. & Aust, D. E. (2008)
World Journal of Gastroenterology, 14(7) pp. 1060-1066. DOI: https://doi.org/10.3748/wjg.14.1060
Details DOI PMID PMC WoS

2008 | Journal Article
Thymidylate synthase genotypes and tumour regression in stage II/III rectal cancer patients after neoadjuvant fluorouracil-based chemoradiation
Stoehlmacher, J.; Goekkurt, E.; Mogck, U.; Aust, D. E.; Kramer, M.; Baretton, G. B. & Liersch, T. et al. (2008)
Cancer Letters, 272(2) pp. 221-225. DOI: https://doi.org/10.1016/j.canlet.2008.07.008
Details DOI PMID PMC WoS

2009 | Journal Article | Letter Note
Comment on "Lymph Nodes After Preoperative Chemoradiotherapy for Rectal Carcinoma: Number, Status, and Impact on Survival"
Sprenger, T. ; Rothe, H.; Langer, C.; Becker, H. & Liersch, T. (2009)
American Journal of Surgical Pathology, 33(7).
Details PMID PMC WoS

2009 | Journal Article
Chromosomal copy number changes of locally advanced rectal cancers treated with preoperative chemoradiotherapy
Grade, M.; Gaedcke, J.; Wangsa, D.; Varma, S.; Beckmann, J.; Liersch, T. & Hess, C. et al. (2009)
CANCER GENETICS AND CYTOGENETICS, 193(1) pp. 19-28. DOI: https://doi.org/10.1016/j.cancergencyto.2009.03.016
Details DOI PMID PMC WoS

2009 | Journal Article
Preoperative chemoradiotherapy in locally advanced rectal cancer: correlation of a gene expression-based response signature with recurrence
Liersch, T.; Grade, M.; Gaedcke, J.; Varma, S.; Difilippantonio, M. J.; Langer, C. & Hess, C. F. et al. (2009)
CANCER GENETICS AND CYTOGENETICS, 190(2) pp. 57-65. DOI: https://doi.org/10.1016/j.cancergencyto.2008.11.011
Details DOI PMID PMC WoS

2009 | Journal Article
Differences Between Clinical Trial Participants and Patients in a Population-Based Registry: the German Rectal Cancer Study vs. the Rostock Cancer Registry
Kalata, P.; Martus, P.; Zettl, H.; Roedel, C.; Hohenberger, W.; Raab, R. & Becker, H. et al. (2009)
Diseases of the Colon & Rectum, 52(3) pp. 425-437. DOI: https://doi.org/10.1007/DCR.0b013e318197d13c
Details DOI PMID PMC WoS

2010 | Journal Article
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
Folprecht, G.; Gruenberger, T.; Bechstein, W. O.; Raab, H.-R.; Lordick, F.; Hartmann, J. T. & Lang, H. et al. (2010)
The Lancet Oncology, 11(1) pp. 38-47.
Details PMID PMC WoS

Researcher

Göttingen All

Sort

issue date

ASC DESC

Items per Page

10 20 50 100